7Baggers
 the precedent: in re: xencor, inc.  Vorys Wed, 01 Oct 2025 17:39:00 GMT
 xencor (nasdaq:xncr) trading 6.2% higher - should you buy?  MarketBeat Fri, 26 Sep 2025 19:21:21 GMT
 xencor (nasdaq:xncr) trading up 5.4% following analyst upgrade  MarketBeat Mon, 22 Sep 2025 09:26:38 GMT
 xencor (nasdaq:xncr) upgraded to strong sell at barclays  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 barclays begins coverage on xencor (nasdaq:xncr)  MarketBeat Mon, 22 Sep 2025 04:35:15 GMT
 xencor (nasdaq:xncr) trading 5.4% higher on analyst upgrade  MarketBeat Sun, 21 Sep 2025 09:56:30 GMT
 xencor (nasdaq:xncr) trading up 5.4% following analyst upgrade  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 barclays begins coverage on xencor (nasdaq:xncr)  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 xencor (nasdaq:xncr) coverage initiated at barclays  MarketBeat Sat, 20 Sep 2025 22:48:21 GMT
 xencor (nasdaq:xncr) stock price up 5.4% after analyst upgrade  MarketBeat Sat, 20 Sep 2025 18:08:15 GMT
 barclays begins coverage on xencor (nasdaq:xncr)  MarketBeat Sat, 20 Sep 2025 12:11:15 GMT
 xencor (nasdaq:xncr) upgraded by barclays to strong sell rating  MarketBeat Sat, 20 Sep 2025 12:11:15 GMT
 Xencor (XNCR) Receives a Sell from Barclays  The Globe and Mail Sat, 20 Sep 2025 08:30:00 GMT
 xencor (nasdaq:xncr) upgraded by barclays to "strong sell" rating  MarketBeat Fri, 19 Sep 2025 11:00:33 GMT
 xencor (nasdaq:xncr) upgraded to "strong sell" at barclays  MarketBeat Fri, 19 Sep 2025 11:00:33 GMT
 Xencor: Bispecific Antibody Program Takes Shape With Q4 Data Release  Seeking Alpha Fri, 19 Sep 2025 07:00:00 GMT
 xencor, inc. $xncr shares bought by goldman sachs group inc.  MarketBeat Thu, 18 Sep 2025 21:53:26 GMT
 xencor (nasdaq:xncr) trading up 5.4% - time to buy?  MarketBeat Thu, 18 Sep 2025 19:52:19 GMT
 is xencor (nasdaq:xncr) weighed on by its debt load?  富途牛牛 Thu, 18 Sep 2025 07:00:00 GMT
 goldman sachs group inc. buys 344,088 shares of xencor, inc. $xncr  MarketBeat Tue, 16 Sep 2025 09:18:19 GMT
 Xencor assumed with an Underweight at Barclays  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 trexquant investment lp raises position in xencor, inc. $xncr  MarketBeat Thu, 11 Sep 2025 19:47:52 GMT
 xencor, inc. $xncr shares purchased by trexquant investment lp  MarketBeat Mon, 08 Sep 2025 12:30:30 GMT
 trexquant investment lp buys 50,119 shares of xencor, inc. $xncr  MarketBeat Mon, 08 Sep 2025 12:30:30 GMT
 xencor (nasdaq:xncr) shares gap down on analyst downgrade  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 bvf inc. il raises position in xencor, inc. $xncr  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 top 10 stocks under $10 that could triple  Insider Monkey Sun, 07 Sep 2025 21:59:36 GMT
 xencor (nasdaq:xncr) given "outperform" rating at wedbush  MarketBeat Sun, 07 Sep 2025 20:37:30 GMT
 xencor (nasdaq:xncr) stock price up 6% - still a buy?  MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
 rbc cuts xencor (xncr) price target but keeps outperform rating  Yahoo Finance Sun, 07 Sep 2025 07:00:00 GMT
 braidwell lp has $17.62 million stake in xencor, inc. $xncr  MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
 jump financial llc purchases shares of 50,473 xencor, inc. $xncr  MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
 Xencor at Cantor Conference: Strategic Advances in Immunology  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 nuveen llc purchases shares of 161,149 xencor, inc. $xncr  MarketBeat Thu, 04 Sep 2025 07:00:00 GMT
 xencor at wells fargo conference: strategic advances in biotech  Investing.com Thu, 04 Sep 2025 00:04:52 GMT
 xencor shares fall after bofa securities downgrade  MarketScreener Wed, 03 Sep 2025 19:21:38 GMT
 erasca, candle, xencor drop as bofa downgrades (eras:nasdaq)  Seeking Alpha Wed, 03 Sep 2025 19:14:48 GMT
 b of a securities downgrades xencor to neutral with $12 pt.  AInvest Wed, 03 Sep 2025 16:02:02 GMT
 bofa securities downgrades xencor to neutral from buy  MarketScreener Wed, 03 Sep 2025 12:23:12 GMT
 published on: 2025-09-03 03:15:31  Newser Wed, 03 Sep 2025 08:15:31 GMT
 Xencor at Wells Fargo Conference: Strategic Advances in Biotech  Investing.com Wed, 03 Sep 2025 07:00:00 GMT

Xencor, Inc
(NASDAQ:XNCR) 

XNCR stock logo

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases in the United states and internationally. The company's product candidates include Obex...

Founded: 1997
Full Time Employees: 166
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends